166 related articles for article (PubMed ID: 17374617)
61. Perspectives for establishment and reorganization of carbohydrate-directed CD antibodies. Report of the carbohydrate section.
Schwartz-Albiez R; Kniep B
Cell Immunol; 2005; 236(1-2):48-50. PubMed ID: 16157317
[TBL] [Abstract][Full Text] [Related]
62. Peptide mimicry of adenocarcinoma-associated carbohydrate antigens.
Kieber-Emmons T; Luo P; Qiu J; Agadjanyan M; Carey L; Hutchins W; Westerink MA; Steplewski Z
Hybridoma; 1997 Feb; 16(1):3-10. PubMed ID: 9085121
[TBL] [Abstract][Full Text] [Related]
63. Evaluating porcine RBC and platelet alpha-galactosyl expression.
MacLaren LA; Riggs CM; Johnstone JE; Doucet J; McAlister VC
Transfusion; 2002 Sep; 42(9):1184-8. PubMed ID: 12430676
[TBL] [Abstract][Full Text] [Related]
64. Enhancement of therapeutic protein in vivo activities through glycoengineering.
Elliott S; Lorenzini T; Asher S; Aoki K; Brankow D; Buck L; Busse L; Chang D; Fuller J; Grant J; Hernday N; Hokum M; Hu S; Knudten A; Levin N; Komorowski R; Martin F; Navarro R; Osslund T; Rogers G; Rogers N; Trail G; Egrie J
Nat Biotechnol; 2003 Apr; 21(4):414-21. PubMed ID: 12612588
[TBL] [Abstract][Full Text] [Related]
65. Phosphorylation of the oncofetal variant of the human bile salt-dependent lipase. identification of phosphorylation site and relation with secretion process.
Verine A; Le Petit-Thevenin J; Panicot-Dubois L; Valette A; Lombardo D
J Biol Chem; 2001 Apr; 276(15):12356-61. PubMed ID: 11148205
[TBL] [Abstract][Full Text] [Related]
66. Polyvalency of Tn (GalNAcalpha1-->Ser/Thr) glycotope as a critical factor for Vicia villosa B4 and glycoprotein interactions.
Wu AM
FEBS Lett; 2004 Mar; 562(1-3):51-8. PubMed ID: 15044001
[TBL] [Abstract][Full Text] [Related]
67. Significance of tumor-associated antigens in the diagnosis and therapy of cancer: an overview.
Kuroki M; Ueno A; Matsumoto H; Abe H; Li T; Imakiire T; Yamauchi Y; Uno K; Shirota K; Shibaguchi H; Kuroki M
Anticancer Res; 2002; 22(6C):4255-64. PubMed ID: 12553066
[TBL] [Abstract][Full Text] [Related]
68. [Establishment of monoclonal antibodies against purified mucin from human pancreatic cell line].
Fujimoto Y; Satake K; Umeyama K; Ho JJ; Kim YS
Nihon Shokakibyo Gakkai Zasshi; 1990 Mar; 87(3):840-7. PubMed ID: 1697002
[TBL] [Abstract][Full Text] [Related]
69. A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide.
Trabbic KR; Whalen K; Abarca-Heideman K; Xia L; Temme JS; Edmondson EF; Gildersleeve JC; Barchi JJ
Sci Rep; 2019 Apr; 9(1):5662. PubMed ID: 30952968
[TBL] [Abstract][Full Text] [Related]
70. The potential immunoregulation of metastases: the use of transfection to produce immunogenic tumor cells.
Itaya T; Schackert H; Frost P
Prog Clin Biol Res; 1989; 288():271-9. PubMed ID: 2717638
[No Abstract] [Full Text] [Related]
71. [Diagnosis of pancreatic carcinoma using 2 associated monoclonal antibodies].
Yao CZ; Zeng XJ; Wang SZ
Zhonghua Wai Ke Za Zhi; 1987 Nov; 25(11):655-8, 670. PubMed ID: 3482539
[No Abstract] [Full Text] [Related]
72. Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells.
Noguchi A; Mukuria CJ; Suzuki E; Naiki M
J Biochem; 1995 Jan; 117(1):59-62. PubMed ID: 7539788
[TBL] [Abstract][Full Text] [Related]
73. From laboratory to clinic: the development of an immunological reagent.
Bright S; Adair J; Secher D
Immunol Today; 1991 Apr; 12(4):130-4. PubMed ID: 2059313
[TBL] [Abstract][Full Text] [Related]
74. Expression of fetoacinar pancreatic (FAP) protein in the pancreatic human tumor cell line BxPC-3.
Mazo A; Fujii Y; Shimotake J; Escribano MJ
Pancreas; 1991 Jan; 6(1):37-45. PubMed ID: 1994378
[TBL] [Abstract][Full Text] [Related]
75. Demonstration of tissue-specific antigens shared by normal pancreas and pancreatic neoplasms.
Sindelar WF; Dresdale AR; Hadley NA
Experientia; 1983 Jan; 39(1):87-9. PubMed ID: 6186518
[TBL] [Abstract][Full Text] [Related]
76. Suppression of porcine xenoantigen expression by dominant-negative effect of alpha-1,3-galactosyltransferase (alpha-1,3-GT) splicing variants.
Ogawa H; Kobayashi I; Nagasaka T; Namil Y; Hayashi S; Kadomatsu K; Maramatsu T; Takagi H
Transplant Proc; 2000 Feb; 32(1):58. PubMed ID: 10700968
[No Abstract] [Full Text] [Related]
77. Expression of Tn, sialosyl-Tn and T antigens in human foetal large intestine.
Grosso M; Vitarelli E; Giuffrè G; Tuccari G; Barresi G
Eur J Histochem; 2000; 44(4):359-63. PubMed ID: 11214861
[TBL] [Abstract][Full Text] [Related]
78. Xenoantigen, an alphaGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell line.
Sawada T; Yamada O; Yoshimura N; Hatori K; Fuchinoue S; Teraoka S
Cancer Cell Int; 2002 Oct; 2(1):14. PubMed ID: 12392598
[TBL] [Abstract][Full Text] [Related]
79. Monocyte-related functions expressed in cell lines established from human pancreatic adenocarcinoma. II. Inhibition of stimulated activity by monoclonal antibodies reacting with surface antigens on tumor cells.
Kern HF; Bosslet K; Sedlacek HH; Schorlemmer HU
Pancreas; 1988; 3(1):2-10. PubMed ID: 2452435
[TBL] [Abstract][Full Text] [Related]
80. Cancer-associated carbohydrates identified by monoclonal antibodies.
Sell S
Hum Pathol; 1990 Oct; 21(10):1003-19. PubMed ID: 2210723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
